Michael Svatoň
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Blood disorders and treatments
-
- Immunodeficiency and Autoimmune Disorders
- Immune Cell Function and Interaction
Papers in
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Eva Froňková (16 shared papers)Anna Šedivá (5 shared papers)Tomáš Kalina (4 shared papers)Adam Klocperk (4 shared papers)Tomáš Milota (4 shared papers)Zuzana Paračková (4 shared papers)Veronika Kanderová (4 shared papers)Markéta Bloomfield (3 shared papers)
- Journals
- Blood (2 papers)Frontiers in Immunology (2 papers)Cancers (2 papers)HemaSphere (2 papers)Journal of Clinical Immunology (2 papers)
- Partner nations
- CzechiaGermanyNetherlands
In The Last Decade
Michael Svatoň
20 papers receiving 313 citations
Peers
Comparison fields: 5 of 47
- Genetics 71
- Immunology 139
- Pathology and Forensic Medicine 85
- Hematology 52
- Transplantation 9
Countries citing papers authored by Michael Svatoň
This map shows the geographic impact of Michael Svatoň's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Svatoň with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Svatoň more than expected).
Fields of papers citing papers by Michael Svatoň
This network shows the impact of papers produced by Michael Svatoň. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Svatoň. The network helps show where Michael Svatoň may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Svatoň, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 63 | |
| 2 | 2018 | 55 | |
| 3 | 2019 | 37 | |
| 4 | 2020 | 29 | |
| 5 | 2014 | 24 | |
| 6 | 2022 | 20 | |
| 7 | 2019 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2019 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2024 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2021 | 2 | |
| 17 | Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score | 2018 | 1 |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About Michael Svatoň
Michael Svatoň is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Immunology, Oncology and Surgery, having authored 23 papers that have together received 315 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Genomics and Diagnostics (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Viral-associated cancers and disorders (3 papers), CAR-T cell therapy research (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Genetics (71 citations), Immunology (139 citations), Pathology and Forensic Medicine (85 citations), Hematology (52 citations) and Transplantation (9 citations). Michael Svatoň has collaborated with scholars based in Czechia, Germany and Netherlands. Frequent co-authors include Eva Froňková, Anna Šedivá, Tomáš Kalina, Adam Klocperk, Tomáš Milota, Zuzana Paračková, Veronika Kanderová, Markéta Bloomfield, Kristina Forsterová and Pavel Klener. Their work appears in journals such as Blood, Frontiers in Immunology, Cancers, HemaSphere and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.